CHAMPIONX CORP (CHX) Fundamental Analysis & Valuation

NASDAQ:CHX • US15872M1045

Current stock price

25.81 USD
-0.79 (-2.97%)
At close:
25.83 USD
+0.02 (+0.08%)
After Hours:

This CHX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. CHX Profitability Analysis

1.1 Basic Checks

  • In the past year CHX was profitable.
  • CHX had a positive operating cash flow in the past year.
  • Of the past 5 years CHX 4 years were profitable.
  • CHX had a positive operating cash flow in each of the past 5 years.
CHX Yearly Net Income VS EBIT VS OCF VS FCFCHX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M -600M

1.2 Ratios

  • With a decent Return On Assets value of 8.37%, CHX is doing good in the industry, outperforming 79.03% of the companies in the same industry.
  • CHX has a better Return On Equity (15.29%) than 77.42% of its industry peers.
  • CHX's Return On Invested Capital of 14.15% is amongst the best of the industry. CHX outperforms 88.71% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for CHX is in line with the industry average of 13.17%.
  • The last Return On Invested Capital (14.15%) for CHX is above the 3 year average (13.65%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROIC 14.15%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
CHX Yearly ROA, ROE, ROICCHX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

  • With a decent Profit Margin value of 8.20%, CHX is doing good in the industry, outperforming 66.13% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CHX has grown nicely.
  • The Operating Margin of CHX (14.41%) is better than 72.58% of its industry peers.
  • CHX's Operating Margin has improved in the last couple of years.
  • With a decent Gross Margin value of 33.16%, CHX is doing good in the industry, outperforming 62.90% of the companies in the same industry.
  • CHX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 14.41%
PM (TTM) 8.2%
GM 33.16%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
CHX Yearly Profit, Operating, Gross MarginsCHX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. CHX Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHX is creating some value.
  • CHX has less shares outstanding than it did 1 year ago.
  • CHX has more shares outstanding than it did 5 years ago.
  • CHX has a better debt/assets ratio than last year.
CHX Yearly Shares OutstandingCHX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CHX Yearly Total Debt VS Total AssetsCHX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • CHX has an Altman-Z score of 3.65. This indicates that CHX is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of CHX (3.65) is better than 85.48% of its industry peers.
  • The Debt to FCF ratio of CHX is 1.74, which is an excellent value as it means it would take CHX, only 1.74 years of fcf income to pay off all of its debts.
  • With an excellent Debt to FCF ratio value of 1.74, CHX belongs to the best of the industry, outperforming 80.65% of the companies in the same industry.
  • CHX has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
  • CHX has a better Debt to Equity ratio (0.31) than 61.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Altman-Z 3.65
ROIC/WACC1.51
WACC9.37%
CHX Yearly LT Debt VS Equity VS FCFCHX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

  • CHX has a Current Ratio of 2.25. This indicates that CHX is financially healthy and has no problem in meeting its short term obligations.
  • CHX has a better Current ratio (2.25) than 67.74% of its industry peers.
  • A Quick Ratio of 1.62 indicates that CHX should not have too much problems paying its short term obligations.
  • CHX has a Quick ratio of 1.62. This is in the better half of the industry: CHX outperforms 61.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.62
CHX Yearly Current Assets VS Current LiabilitesCHX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. CHX Growth Analysis

3.1 Past

  • CHX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.63%.
  • CHX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.09% yearly.
  • Looking at the last year, CHX shows a decrease in Revenue. The Revenue has decreased by -4.17% in the last year.
  • Measured over the past years, CHX shows a very strong growth in Revenue. The Revenue has been growing by 26.29% on average per year.
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%

3.2 Future

  • The Earnings Per Share is expected to grow by 6.80% on average over the next years.
  • CHX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.82% yearly.
EPS Next Y6.36%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
EPS Next 5Y6.8%
Revenue Next Year-5.3%
Revenue Next 2Y-2.49%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.82%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHX Yearly Revenue VS EstimatesCHX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B 5B
CHX Yearly EPS VS EstimatesCHX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

More info and screens

Find the best growth stocksShow best growing peers

4

4. CHX Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 14.26 indicates a correct valuation of CHX.
  • Based on the Price/Earnings ratio, CHX is valued a bit cheaper than 64.52% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.21. CHX is valued slightly cheaper when compared to this.
  • The Price/Forward Earnings ratio is 13.24, which indicates a correct valuation of CHX.
  • The rest of the industry has a similar Price/Forward Earnings ratio as CHX.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.13, CHX is valued a bit cheaper.
Industry RankSector Rank
PE 14.26
Fwd PE 13.24
CHX Price Earnings VS Forward Price EarningsCHX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHX is on the same level as its industry peers.
  • CHX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 14.43
EV/EBITDA 6.58
CHX Per share dataCHX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CHX does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of CHX may justify a higher PE ratio.
PEG (NY)2.24
PEG (5Y)1.29
EPS Next 2Y3.8%
EPS Next 3Y5.08%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. CHX Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 1.47%, CHX has a reasonable but not impressive dividend return.
  • CHX's Dividend Yield is a higher than the industry average which is at 0.98.
  • Compared to the average S&P500 Dividend Yield of 1.89, CHX is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.47%

5.2 History

  • The dividend of CHX decreases each year by -47.78%.
  • CHX has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)-47.78%
Div Incr Years2
Div Non Decr Years2
CHX Yearly Dividends per shareCHX Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

  • 24.70% of the earnings are spent on dividend by CHX. This is a low number and sustainable payout ratio.
DP24.7%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
CHX Yearly Income VS Free CF VS DividendCHX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M
CHX Dividend Payout.CHX Dividend Payout, showing the Payout Ratio.CHX Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CHX Fundamentals: All Metrics, Ratios and Statistics

CHAMPIONX CORP

NASDAQ:CHX (7/15/2025, 8:00:00 PM)

After market: 25.83 +0.02 (+0.08%)

25.81

-0.79 (-2.97%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)07-18
Earnings (Next)10-21
Inst Owners95.44%
Inst Owner Change0%
Ins Owners0.99%
Ins Owner Change0%
Market Cap4.94B
Revenue(TTM)3.58B
Net Income(TTM)293.14M
Analysts86.67
Price Target42.23 (63.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.47%
Yearly Dividend0.37
Dividend Growth(5Y)-47.78%
DP24.7%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.44%
Min EPS beat(2)0.36%
Max EPS beat(2)14.53%
EPS beat(4)2
Avg EPS beat(4)-2.36%
Min EPS beat(4)-19.69%
Max EPS beat(4)14.53%
EPS beat(8)4
Avg EPS beat(8)0.56%
EPS beat(12)8
Avg EPS beat(12)1.75%
EPS beat(16)11
Avg EPS beat(16)1.71%
Revenue beat(2)0
Avg Revenue beat(2)-2.81%
Min Revenue beat(2)-4.47%
Max Revenue beat(2)-1.16%
Revenue beat(4)0
Avg Revenue beat(4)-4.29%
Min Revenue beat(4)-7.8%
Max Revenue beat(4)-1.16%
Revenue beat(8)0
Avg Revenue beat(8)-3.77%
Revenue beat(12)2
Avg Revenue beat(12)-2.06%
Revenue beat(16)5
Avg Revenue beat(16)-1.12%
PT rev (1m)0%
PT rev (3m)-1.9%
EPS NQ rev (1m)-2.98%
EPS NQ rev (3m)-4.17%
EPS NY rev (1m)-6.47%
EPS NY rev (3m)-10.47%
Revenue NQ rev (1m)-1.62%
Revenue NQ rev (3m)-4.6%
Revenue NY rev (1m)-2.24%
Revenue NY rev (3m)-7.4%
Valuation
Industry RankSector Rank
PE 14.26
Fwd PE 13.24
P/S 1.38
P/FCF 14.43
P/OCF 10.23
P/B 2.58
P/tB 4.71
EV/EBITDA 6.58
EPS(TTM)1.81
EY7.01%
EPS(NY)1.95
Fwd EY7.56%
FCF(TTM)1.79
FCFY6.93%
OCF(TTM)2.52
OCFY9.77%
SpS18.68
BVpS10.01
TBVpS5.48
PEG (NY)2.24
PEG (5Y)1.29
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 8.37%
ROE 15.29%
ROCE 18.98%
ROIC 14.15%
ROICexc 17.55%
ROICexgc 29.07%
OM 14.41%
PM (TTM) 8.2%
GM 33.16%
FCFM 9.57%
ROA(3y)7.83%
ROA(5y)1.06%
ROE(3y)15.08%
ROE(5y)1.18%
ROIC(3y)13.65%
ROIC(5y)9.48%
ROICexc(3y)15.86%
ROICexc(5y)10.93%
ROICexgc(3y)28.04%
ROICexgc(5y)19.36%
ROCE(3y)18.31%
ROCE(5y)12.72%
ROICexgc growth 3Y47.18%
ROICexgc growth 5Y16.9%
ROICexc growth 3Y46.83%
ROICexc growth 5Y30.42%
OM growth 3Y32.96%
OM growth 5Y8.66%
PM growth 3Y33.74%
PM growth 5Y13.82%
GM growth 3Y10.44%
GM growth 5Y-0.48%
F-Score6
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 1.74
Debt/EBITDA 0.78
Cap/Depr 57.1%
Cap/Sales 3.93%
Interest Coverage 250
Cash Conversion 63.4%
Profit Quality 116.78%
Current Ratio 2.25
Quick Ratio 1.62
Altman-Z 3.65
F-Score6
WACC9.37%
ROIC/WACC1.51
Cap/Depr(3y)53.43%
Cap/Depr(5y)43.4%
Cap/Sales(3y)3.46%
Cap/Sales(5y)3.1%
Profit Quality(3y)155.68%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1.63%
EPS 3Y44.49%
EPS 5Y11.09%
EPS Q2Q%0%
EPS Next Y6.36%
EPS Next 2Y3.8%
EPS Next 3Y5.08%
EPS Next 5Y6.8%
Revenue 1Y (TTM)-4.17%
Revenue growth 3Y5.73%
Revenue growth 5Y26.29%
Sales Q2Q%-6.25%
Revenue Next Year-5.3%
Revenue Next 2Y-2.49%
Revenue Next 3Y-1.12%
Revenue Next 5Y2.82%
EBIT growth 1Y0.17%
EBIT growth 3Y40.57%
EBIT growth 5Y37.22%
EBIT Next Year52.58%
EBIT Next 3Y14.47%
EBIT Next 5Y9.48%
FCF growth 1Y-23.96%
FCF growth 3Y22.54%
FCF growth 5Y31.03%
OCF growth 1Y-12.01%
OCF growth 3Y21.57%
OCF growth 5Y30.48%

CHAMPIONX CORP / CHX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CHAMPIONX CORP (CHX) stock?

ChartMill assigns a fundamental rating of 6 / 10 to CHX.


Can you provide the valuation status for CHAMPIONX CORP?

ChartMill assigns a valuation rating of 4 / 10 to CHAMPIONX CORP (CHX). This can be considered as Fairly Valued.


How profitable is CHAMPIONX CORP (CHX) stock?

CHAMPIONX CORP (CHX) has a profitability rating of 8 / 10.


What is the valuation of CHAMPIONX CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CHAMPIONX CORP (CHX) is 14.26 and the Price/Book (PB) ratio is 2.58.


Can you provide the financial health for CHX stock?

The financial health rating of CHAMPIONX CORP (CHX) is 8 / 10.